DermBiont

DermBiont

Verified
Skin microbiome therapeutics platform to treat and prevent skin diseases.

Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$140m (Public information from Oct 2023)
Cambridge Massachusetts (HQ)
Deals in current and previous year:
  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor investor investor

$0.0

round
N/A

$0.0

round
investor investor investor investor investor

$0.0

round
N/A

$0.0

round
N/A

$0.0

round
investor investor investor investor

$0.0

Valuation: $0.0

round
*
N/A

$8.1m

Convertible
Total Funding000k

Recent News about DermBiont

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by DermBiont

Edit
Chromaderm
ACQUISITION by DermBiont Dec 2021